The postpolio syndrome (PPS) is characterized by progressive disabilities decades after recovery from the acute paralytic disease. There are reports on intrathecal inflammatory reactions in PPS, including increased expression of cytokines by cerebrospinal fluid (CSF) mononuclear cells (CSF-MC). This is potentially of relevance for the clinical condition. We here explored if cytokine expression in the CSF of PPS patients could be modulated by high-dose intravenous immunoglobulins (IvIg). The expression of TNF-a, IFN-g, IL-10 and IL-4 mRNAs was measured by real-time RT-PCR in CSF and peripheral blood mononuclear cells (PBMC) of 16 PPS patients before, and 6 -8 weeks after IvIg treatment, and in 26 patients with noninflammatory other neurological diseases (OND).
Introduction
Progressive muscular weakness, disabling fatigue and pain occurring decades after acute poliomyelitis clinically characterize the postpolio syndrome (PPS) (Borg, 1996) . An ongoing denervation/reinnervation process and a failing capacity to maintain large motor units result in an uncompensated loss of motor units and decrease of strength (Borg, 1996; Grimby et al., 1998) . The peripheral denervation has been suggested to be caused by overstress and/or agedependent degeneration of remaining motor units (Borg, 1996) . Another perhaps less favored and less explored hypothesis for the excessive loss of motor units is that of chronic persistent inflammation within the central nervous system (CNS). This would be consistent with the observations of elevated markers of inflammation in the cerebrospinal fluid (CSF) of PPS patients (Ginsberg et al., 1989; Sharief et al., 1991) . Furthermore, inflammation in the spinal cord has been demonstrated in autopsies of PPS cases (Miller, 1995; Pezeshkpour and Dalakas, 1987) . The cause and relevance of such an inflammation has remained unclear.
We recently obtained further support for the presence of a chronic inflammatory process in PPS. Persons with PPS displayed increased numbers of CSF mononuclear cells (CSF-MC) expressing mRNA for inflammatory cytokines. The levels of expression were in the range of that in multiple sclerosis (MS), a disease with a well-accepted inflammatory component (Gonzalez et al., 2002) . Long-term overproduction of cytokines may cause tissue damage in the CNS, including death of neurons (Campbell, 1995; Campbell et al., 1993; Pagenstecher et al., 2000; Probert et al., 1995) .
Hypothetically, there could be a causal link between the increased intrathecal cytokine production and the clinical manifestations of PPS. As a first step to study this hypothesis, we here examined if IvIg is able to dampen intrathecal 
